Does paroxetine cause cardiac malformations? (Q46373552)

21 December 2017

meta-analysis

0 references

title

Does paroxetine cause cardiac malformations? (English)

1 reference

21 December 2017

4

Adrienne Einarson

1 reference

21 December 2017

5

Gideon Koren

1 reference

21 December 2017

author name string

Lisa O'Brien

series ordinal

1

1 reference

21 December 2017

Thomas R Einarson

series ordinal

2

1 reference

21 December 2017

Moumita Sarkar

series ordinal

3

1 reference

21 December 2017

publication date

1 August 2008

1 reference

21 December 2017

Journal of Obstetrics and Gynaecology Canada

published in

1 reference

21 December 2017

volume

30

1 reference

21 December 2017

issue

8

1 reference

21 December 2017

page(s)

696-701

1 reference

21 December 2017

Drug use by pregnant women and comparable non-pregnant women in The Netherlands with reference to the Australian classification system

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Prevalence and patterns of antidepressant drug use during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Use of antidepressant medications during pregnancy: a multisite study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Risks associated with selective serotonin reuptake inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Antidepressant drugs during pregnancy and infant congenital heart defect

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The safety of newer antidepressants in pregnancy and breastfeeding

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Serotonin reuptake inhibitors in pregnancy and the risk of major malformations: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Teratogenicity of SSRIs--serious concern or much ado about little?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Delivery outcome after the use of antidepressants in early pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Birth outcomes after prenatal exposure to antidepressant medication

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Birth outcomes following prenatal exposure to antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Outcomes of prenatal antidepressant exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The use of selective serotonin reuptake inhibitors in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Perinatal outcome following third trimester exposure to paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Paroxetine in the first trimester and the prevalence of congenital malformations

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The incidence of congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

The file drawer problem and tolerance for null results

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

BIAS AGAINST THE NULL HYPOTHESIS: THE REPRODUCTIVE HAZARDS OF COCAINE

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

SSRI'S and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2932918-8

7 January 2021

10.1016/S1701-2163(16)32918-8

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017